Bristol-Myers Squibb Company PFD CONV 2
BMYMP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10,346,000 | $11,464,000 | $9,123,000 | $13,979,000 |
| Short-Term Investments | $513,000 | $816,000 | $130,000 | $3,242,000 |
| Receivables | $14,424,000 | $15,264,000 | $13,937,000 | $12,516,000 |
| Inventory | $2,557,000 | $2,662,000 | $2,339,000 | $2,095,000 |
| Other Curr. Assets | $1,940,000 | $1,564,000 | $1,744,000 | $1,430,000 |
| Total Curr. Assets | $29,780,000 | $31,770,000 | $27,273,000 | $33,262,000 |
| Property Plant & Equip (Net) | $8,360,000 | $8,036,000 | $7,475,000 | $6,968,000 |
| Goodwill | $21,719,000 | $21,169,000 | $21,149,000 | $20,502,000 |
| Intangibles | $23,643,000 | $27,485,000 | $36,355,000 | $42,775,000 |
| Long-Term Investments | $2,508,000 | $2,499,000 | $2,187,000 | $2,713,000 |
| Tax Assets | $4,236,000 | $2,768,000 | $1,344,000 | $1,439,000 |
| Other NC Assets | $2,357,000 | $1,432,000 | $1,037,000 | $1,655,000 |
| Total NC Assets | $62,823,000 | $63,389,000 | $69,547,000 | $76,052,000 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $92,603,000 | $95,159,000 | $96,820,000 | $109,314,000 |
| Liabilities | – | – | – | – |
| Payables | $3,602,000 | $3,259,000 | $3,040,000 | $2,949,000 |
| Short-Term Debt | $2,046,000 | $3,119,000 | $4,264,000 | $4,948,000 |
| Tax Payable | $1,514,000 | $1,371,000 | $942,000 | $754,000 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $14,601,000 | $12,789,000 | $11,991,000 | $11,484,000 |
| Total Curr. Liab. | $23,774,000 | $22,262,000 | $21,890,000 | $21,868,000 |
| LT Debt | $47,603,000 | $36,653,000 | $35,056,000 | $39,605,000 |
| Deferred Rev, NC | $230,000 | $300,000 | $283,000 | $326,000 |
| Deferred Tax Liab, NC | $369,000 | $338,000 | $2,166,000 | $4,501,000 |
| Other NC Liab. | $2,869,000 | $4,591,000 | $5,046,000 | $6,134,000 |
| Total NC Liab. | $52,441,000 | $43,412,000 | $43,812,000 | $51,440,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1,551,000 | $1,692,000 | $1,397,000 | $1,043,000 |
| Total Liabilities | $76,215,000 | $65,674,000 | $65,702,000 | $73,308,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $292,000 | $292,000 | $292,000 | $292,000 |
| Retained Earnings | $14,912,000 | $28,766,000 | $25,503,000 | $23,820,000 |
| AOCI | -$1,238,000 | -$1,546,000 | -$1,281,000 | -$1,268,000 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $16,335,000 | $29,430,000 | $31,061,000 | $35,946,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $53,000 | $55,000 | $57,000 | $60,000 |
| Total Liab. & Tot. Equity | $92,603,000 | $95,159,000 | $96,820,000 | $109,314,000 |
| Net Debt | $39,303,000 | $28,308,000 | $30,197,000 | $30,574,000 |